Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Source And Potency Of Stem Cells01:27

Source And Potency Of Stem Cells

6.9K
Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
6.9K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

6.1K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
6.1K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

4.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined senolytics induce varied phenotypic and functional responses on senescent phenotypes of mesenchymal stromal cell populations.

Biochimie·2026
Same author

Validation of a novel genomic biomarker of mesenchymal stem cell scalability and implications of genotype status on cellular senescence phenotypes.

Scientific reports·2026
Same author

From Theory to Practice: Serious Game Education in Singapore and Canada.

Cureus·2026
Same author

Heparan sulfate as a central modulator of growth factor dynamics in tissue regeneration.

APL bioengineering·2025
Same author

Individualized Medicine in the Era of Artificial Intelligence.

Mayo Clinic proceedings·2025
Same author

Microplastics and Nanoplastics and the Digestive System.

Gastro hep advances·2025

Related Experiment Video

Updated: Apr 16, 2026

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

2.1K

Establishing criteria for human mesenchymal stem cell potency.

Rebekah M Samsonraj1, Bina Rai1,2, Padmapriya Sathiyanathan3,4

  • 1Glycotherapeutics Group.

Stem Cells (Dayton, Ohio)
|March 11, 2015
PubMed
Summary

Identifying mesenchymal stem cell (MSC) potency requires more than standard criteria. High-growth capacity MSCs, identified by specific biomarkers, demonstrate superior bone-forming ability, crucial for therapeutic applications.

Keywords:
Growth capacityMesenchymal stem/stromal cellsPDGFR-αPotencyQualitySTRO-1

More Related Videos

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs
06:20

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs

Published on: December 24, 2015

13.0K
High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

11.3K

Related Experiment Videos

Last Updated: Apr 16, 2026

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

2.1K
Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs
06:20

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs

Published on: December 24, 2015

13.0K
High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

11.3K

Area of Science:

  • Stem Cell Biology
  • Regenerative Medicine
  • Biomarker Discovery

Background:

  • Mesenchymal stem cells (MSCs) are crucial for tissue regeneration but their therapeutic potency varies significantly between donors.
  • Standard criteria, such as adherence to plastic and International Society for Cellular Therapy (ISCT) guidelines, do not reliably predict MSC potency.
  • Donor-derived variability in MSC growth capacity necessitates the identification of critical determinants for assessing potency.

Purpose of the Study:

  • To identify critical determinants of mesenchymal stem cell (MSC) potency.
  • To differentiate between high-growth capacity and low-growth capacity MSCs based on in vitro and in vivo attributes.
  • To establish improved criteria for assessing MSC quality for therapeutic applications.

Main Methods:

  • Isolation and characterization of bone marrow-derived MSCs from age- and sex-matched donors.
  • Assessment of in vitro attributes including adherence to plastic, colony-forming efficiency, and long-term expansion capacity.
  • Cell-surface biomarker analysis (including STRO-1 and platelet-derived growth factor receptor alpha) and mRNA transcript expression (TWIST-1, DERMO-1).
  • Evaluation of in vivo potency through ectopic bone formation assays.

Main Results:

  • MSCs could be categorized into high-growth capacity and low-growth capacity groups, with high-growth cells being smaller, having greater colony-forming efficiency, and longer telomeres.
  • ISCT criteria did not distinguish between growth capacities, but STRO-1 and platelet-derived growth factor receptor alpha expression, along with TWIST-1 and DERMO-1 mRNA, were higher in high-growth MSCs.
  • Both MSC groups produced similar levels of regenerative factors and exhibited multilineage differentiation, but high-growth MSCs formed double the volume of mineralized tissue in ectopic bone formation assays.
  • High-growth capacity MSCs demonstrated superior in vivo bone-forming potential compared to low-growth capacity MSCs.

Conclusions:

  • Additional phenotypic criteria beyond current ISCT standards are essential for accurately assessing MSC potency.
  • STRO-1, platelet-derived growth factor receptor alpha, TWIST-1, and DERMO-1 show promise as biomarkers for identifying potent MSCs.
  • The findings provide a basis for improved quality control of MSCs before therapeutic use, particularly for bone regeneration applications.